Multiple Myeloma Stem Cell Transplant Didn T Work

You have a stem cell transplant after very high doses of chemotherapy usually melphalan.

Multiple myeloma stem cell transplant didn t work.

This could be because your donor s cells haven t been accepted by your body that your original condition has come back or other complications such as graft vs host disease. It can be a strong weapon in your fight against multiple myeloma. Autologous stem cell transplant can provide significant remission that is both long and deep extending survival. This is called an autologous stem cell transplant.

When stem cell transplants were first developed the new stem cells came from bone marrow and so this was known as a bone marrow. The chemotherapy has a good chance of killing the myeloma cells but it also kills the healthy stem cells in your bone marrow. Stem cell transplant for multiple myeloma. In a stem cell transplant the patient gets high dose chemotherapy to kill the cells in the bone marrow.

You may be a candidate for a bone marrow transplant also known as a stem cell transplant when other therapies prove ineffective. Multiple myeloma also known as kahler s disease is a type of blood cancer there s no cure but treatments can slow its spread and sometimes make symptoms go away. Then the patient receives new healthy blood forming stem cells. The standard of care for fit multiple myeloma patients is to receive high dose chemotherapy hdt with autologous stem cell rescue otherwise known as autologous stem cell transplant asct after completion of induction therapy.

Before your high dose chemotherapy your team collects your stem cells. A referral is not required to consult with our oncologists specializing in multiple myeloma. This is an improvement on the 60 90 overall response rates and 11 20 complete response rates using combo therapies without transplant like daratumumab carfilzomib elotuzumab or panobinostat. A stem cell transplant replaces unhealthy blood cells with healthy ones.

In the study overall response rates for all patients who all received stem cell transplant was 80 and 22 achieved complete response. Your medical team will always monitor you closely so they can address any problems as soon. The long term survival of people with multiple myeloma following autologous stem cell transplant has steadily improved since 1997 through with the introduction of new medicines a large review study reports. Multiple myeloma is a blood cancer.

Older patients and those with low risk disease show the greatest gains over time while people with high risk factors showed the least change its researchers said. If you would like more information about multiple myeloma treatment and stem cell transplantation call 1 888 663 3488 or complete a new patient registration form online.